urea has been researched along with Benign Psychomotor Epilepsy, Childhood in 8 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind cross-over trial between pheneturide and phenytoin in ninety-four outpatients with epilepsy is described." | 9.05 | A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial. ( Engler, C; English, JR; Fry, DE; Gawel, MJ; Gibberd, FB; Page, NG; Park, DM; Rose, FC; Scott, G, 1982) |
| "A double-blind cross-over trial between pheneturide and phenytoin in ninety-four outpatients with epilepsy is described." | 5.05 | A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial. ( Engler, C; English, JR; Fry, DE; Gawel, MJ; Gibberd, FB; Page, NG; Park, DM; Rose, FC; Scott, G, 1982) |
| " Creatinine concentrations should not be considered when dosage adjustments of renally eliminated drugs are being calculated for patients with such metabolic interferences." | 1.29 | Creatinine metabolism impairment by an anticonvulsant drug, phenacemide. ( Baltassat, P; Cahen, R; Francois, B; Louisot, P; Martin, A, 1994) |
| "Phenacemide therapy was well tolerated with a minimum of untoward side effects and no evidence of irreversible drug toxicity." | 1.27 | Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations. ( Coker, SB; Egel, RT; Holmes, EW, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (62.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Godoy, LD | 2 |
| Liberato, JL | 2 |
| Celani, MVB | 1 |
| Gobbo-Neto, L | 1 |
| Lopes, NP | 2 |
| Dos Santos, WF | 2 |
| Cunha, AOS | 1 |
| Mortari, MR | 1 |
| de Oliveira Beleboni, R | 1 |
| Fontana, ACK | 1 |
| Bilikiewicz, T | 1 |
| Gromska, J | 1 |
| Vas, CJ | 1 |
| Parsonage, MJ | 1 |
| Gibberd, FB | 1 |
| Park, DM | 1 |
| Scott, G | 1 |
| Gawel, MJ | 1 |
| Fry, DE | 1 |
| Page, NG | 1 |
| Engler, C | 1 |
| English, JR | 1 |
| Rose, FC | 1 |
| Cahen, R | 1 |
| Martin, A | 1 |
| Francois, B | 1 |
| Baltassat, P | 1 |
| Louisot, P | 1 |
| Coker, SB | 1 |
| Holmes, EW | 1 |
| Egel, RT | 1 |
| Hershon, HI | 1 |
| Parsonage, M | 1 |
2 trials available for urea and Benign Psychomotor Epilepsy, Childhood
| Article | Year |
|---|---|
A comparison of phenytoin and pheneturide in patients with epilepsy: a double-blind cross-over trial.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Clinical Trials as Topic; Double-Blind Method; Epilepsies, | 1982 |
Comparative trial of diazepam and pheneturide in treatment of epilepsy.
Topics: Age Factors; Diazepam; Epilepsy; Epilepsy, Temporal Lobe; Female; Humans; Male; Stress, Psychologica | 1969 |
6 other studies available for urea and Benign Psychomotor Epilepsy, Childhood
| Article | Year |
|---|---|
Disease Modifying Effects of the Spider Toxin Parawixin2 in the Experimental Epilepsy Model.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Lithium; Mal | 2017 |
Parawixin2 Protects Hippocampal Cells in Experimental Temporal Lobe Epilepsy.
Topics: Animals; Disease Models, Animal; Epilepsy, Temporal Lobe; Hippocampus; Male; Neurons; Neuroprotectiv | 2018 |
[In defense of phenyl-acetylurea (Neophenal)].
Topics: Anticonvulsants; Epilepsy, Temporal Lobe; Humans; Urea | 1967 |
Treatment of intractable temporal lobe epilepsy with pheneturide.
Topics: Adolescent; Adult; Alkaline Phosphatase; Anticonvulsants; Ataxia; Child; Epilepsy, Temporal Lobe; Hu | 1967 |
Creatinine metabolism impairment by an anticonvulsant drug, phenacemide.
Topics: Adult; Anticonvulsants; Benzeneacetamides; Carbamazepine; Creatinine; Epilepsy, Temporal Lobe; Glome | 1994 |
Phenacemide therapy of complex partial epilepsy in children: determination of plasma drug concentrations.
Topics: Adolescent; Benzeneacetamides; Child; Child, Preschool; Epilepsy, Temporal Lobe; Female; Humans; Mal | 1987 |